Allahabad High Court : Deceased Farmer’s Odd Jobs Don’t Bar Family from Scheme Benefits || Secured Creditors' Dues Take Priority Over Govt Claims: Allahabad HC on SARFAESI & RDB Acts || Daughter Can’t Claim Mitakshara Father’s Property if He Died Pre-1956 & Son Survives: HC || Gujarat High Court: Sessions Court Can’t Suspend Sentence Just to Allow Revision Filing || Delhi High Court: Non-Combat Security Roles Crucial; Minor Lapse Risks National Safety || Punjab & Haryana HC: Allegation of Harassment Alone Insufficient to Prove Abetment to Suicide || Orissa HC: Directors Liable under S.138 NI Act Despite Company’s Insolvency || Bombay HC: GST Return Details of Company Exempt from Disclosure under RTI Act || Chhattisgarh HC: Timely Appointment of Electronic Evidence Examiners Vital in Cyber Crime Probes || Bombay HC: GST Return Details of Company Exempt from Disclosure under RTI Act

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :